MONDAY DEADLINE: NRx Pharmaceuticals, Inc. Investors with Si

/PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP; NRXPW) securities between...

Related Keywords

San Diego , California , United States , Robbins Geller , Nrx Pharma , Dal Bosco , Enron Corp , Drug Administration , Prnewswire Robbins Geller Rudman Dowd , Nrx Pharmaceuticals Inc , Nasdaq , Robbins Geller Rudman Dowd , Securities Class Action Services Top , Securities Exchange , Securities Exchange Act , Emergency Use Authorization , Class Period , Private Securities Litigation Reform Act , Robbins Geller Rudman , Class Action Services Top , Geller Rudman , Robbins Geller Rudman Amp Dowd Llp ,